The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.5, 2003-10, pp. : 623-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attacking c-Myc: Targeted and Combined Therapies for Cancer

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6543-6554

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2890-2898

Bentham Science Publishers

Access to resources Recommend Favorite

The MYC Oncogene as a Cancer Drug Target

Current Cancer Drug Targets, Vol. 3, Iss. 3, 2003-06 ,pp. : 163-175

Bentham Science Publishers

Access to resources Recommend Favorite

The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders

By Roskoski Robert

Expert Opinion on Drug Discovery, Vol. 8, Iss. 9, 2013-09 ,pp. : 1165-1179

Informa Healthcare

Access to resources Recommend Favorite

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

By Miura Koh Karasawa Hideaki Sasaki Iwao

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1333-1345

Informa Healthcare

Access to resources Recommend Favorite